S&P 500   4,247.08 (-0.62%)
DOW   33,362.47 (-0.76%)
QQQ   351.91 (-0.65%)
AAPL   169.54 (-1.41%)
MSFT   310.14 (-0.64%)
META   292.47 (-2.17%)
GOOGL   129.16 (+0.46%)
AMZN   125.37 (-0.48%)
TSLA   236.13 (-3.27%)
NVDA   418.00 (-0.26%)
NIO   8.35 (-0.71%)
BABA   85.63 (-0.33%)
AMD   97.00 (+1.08%)
T   14.81 (-1.40%)
F   12.28 (-1.21%)
MU   67.07 (-1.28%)
CGC   0.86 (-7.06%)
GE   110.42 (+0.45%)
DIS   79.32 (-0.91%)
AMC   7.65 (-3.29%)
PFE   31.98 (-1.30%)
PYPL   56.77 (-3.67%)
NFLX   376.94 (-0.61%)
S&P 500   4,247.08 (-0.62%)
DOW   33,362.47 (-0.76%)
QQQ   351.91 (-0.65%)
AAPL   169.54 (-1.41%)
MSFT   310.14 (-0.64%)
META   292.47 (-2.17%)
GOOGL   129.16 (+0.46%)
AMZN   125.37 (-0.48%)
TSLA   236.13 (-3.27%)
NVDA   418.00 (-0.26%)
NIO   8.35 (-0.71%)
BABA   85.63 (-0.33%)
AMD   97.00 (+1.08%)
T   14.81 (-1.40%)
F   12.28 (-1.21%)
MU   67.07 (-1.28%)
CGC   0.86 (-7.06%)
GE   110.42 (+0.45%)
DIS   79.32 (-0.91%)
AMC   7.65 (-3.29%)
PFE   31.98 (-1.30%)
PYPL   56.77 (-3.67%)
NFLX   376.94 (-0.61%)
S&P 500   4,247.08 (-0.62%)
DOW   33,362.47 (-0.76%)
QQQ   351.91 (-0.65%)
AAPL   169.54 (-1.41%)
MSFT   310.14 (-0.64%)
META   292.47 (-2.17%)
GOOGL   129.16 (+0.46%)
AMZN   125.37 (-0.48%)
TSLA   236.13 (-3.27%)
NVDA   418.00 (-0.26%)
NIO   8.35 (-0.71%)
BABA   85.63 (-0.33%)
AMD   97.00 (+1.08%)
T   14.81 (-1.40%)
F   12.28 (-1.21%)
MU   67.07 (-1.28%)
CGC   0.86 (-7.06%)
GE   110.42 (+0.45%)
DIS   79.32 (-0.91%)
AMC   7.65 (-3.29%)
PFE   31.98 (-1.30%)
PYPL   56.77 (-3.67%)
NFLX   376.94 (-0.61%)
S&P 500   4,247.08 (-0.62%)
DOW   33,362.47 (-0.76%)
QQQ   351.91 (-0.65%)
AAPL   169.54 (-1.41%)
MSFT   310.14 (-0.64%)
META   292.47 (-2.17%)
GOOGL   129.16 (+0.46%)
AMZN   125.37 (-0.48%)
TSLA   236.13 (-3.27%)
NVDA   418.00 (-0.26%)
NIO   8.35 (-0.71%)
BABA   85.63 (-0.33%)
AMD   97.00 (+1.08%)
T   14.81 (-1.40%)
F   12.28 (-1.21%)
MU   67.07 (-1.28%)
CGC   0.86 (-7.06%)
GE   110.42 (+0.45%)
DIS   79.32 (-0.91%)
AMC   7.65 (-3.29%)
PFE   31.98 (-1.30%)
PYPL   56.77 (-3.67%)
NFLX   376.94 (-0.61%)
Positive News SentimentPositive News
NASDAQ:MBOT

Microbot Medical (MBOT) Stock Forecast, Price & News

$1.33
-0.02 (-1.47%)
(As of 01:45 PM ET)
Compare
Today's Range
$1.33
▼
$1.38
50-Day Range
$1.33
▼
$2.68
52-Week Range
$1.00
▼
$5.50
Volume
25,178 shs
Average Volume
1.39 million shs
Market Capitalization
$15.58 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.00
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media

Microbot Medical MarketRank™ Forecast

Analyst Rating
0.00 Rating Score
Upside/​Downside
488.2% Upside
$8.00 Price Target
Short Interest
Healthy
1.40% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($1.09) to ($0.64) Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.49 out of 5 stars

Medical Sector

802nd out of 963 stocks

Biological Products, Except Diagnostic Industry

127th out of 159 stocks

See Top Rated MarketRank™ Stocks Here

MBOT stock logo

About Microbot Medical (NASDAQ:MBOT) Stock

Microbot Medical Inc. operates as a pre-clinical medical device company in the United Kingdom. It primarily engages in the research, design, and development of next generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company also offers LIBERTY, a robotic system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination. In addition, it provides One & Done Technology, an endovascular robotic system for a range of applications in cardiovascular, peripheral vascular, and neurovascular spaces; and NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. Further, the company offers ViRob, an autonomous crawling micro-robot which can be controlled remotely to navigate and crawl in different natural spaces within the human body, including blood vessels, digestive tract, and respiratory system, as well as artificial spaces, such as shunts, catheters, ports, etc. Additionally, it provides ipCAT, a disposable self-propelled locomotive device that is designed to advance in tubular anatomies. The company also has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is headquartered in Hingham, Massachusetts.

MBOT Price History

MBOT Stock News Headlines

September 27, 2023 | finance.yahoo.com
Microbot Medical Engages CRO to Support its Upcoming U.S. Pivotal Clinical Trial
September 19, 2023 | americanbankingnews.com
Head to Head Analysis: Microbot Medical (NASDAQ:MBOT) vs. Halozyme Therapeutics (NASDAQ:HALO)
September 27, 2023 | Micro-Cap Stock Trader (Ad)
U.S. drive to onshore battery supply chains could create big winners in lithium
Investor Find Lithium Gold and Crush the Bear Market with 32k Metric Tons
September 8, 2023 | finance.yahoo.com
Microbot Medical Gains Global Recognition; Professor Vincent Vidal to Present an Abstract on The LIBERTY® Robotic Surgical System at CIRSE 2023
August 17, 2023 | markets.businessinsider.com
Analysts Are Bullish on These Healthcare Stocks: AIM ImmunoTech (AIM), Microbot Medical (MBOT)
August 16, 2023 | finance.yahoo.com
Is Microbot Medical (NASDAQ:MBOT) In A Good Position To Deliver On Growth Plans?
August 15, 2023 | finance.yahoo.com
Microbot Medical Boosts Manufacturing and Commercialization Capabilities for its Robotic Surgical System
August 10, 2023 | finance.yahoo.com
Microbot Medical Strengthens Its Position Among US Interventional Radiologists by Appointing Professor Francois H. Cornelis to Its Scientific Advisory Board
September 27, 2023 | Wall Street Fundamentals (Ad)
The "Plug and Play" Model Putting Online Giants to Shame
While e-commerce has been undergoing a turbulent time, a "simple" model has grown 4X faster than Amazon over the last 3 years. Applying this model to high-margin, recession-resistant businesses has shown to be profitable. But that's just the beginning of explaining the 400+% growth - and potential - of this "diamond in the rough."
August 4, 2023 | benzinga.com
Chief Financial Officer at Microbot Medical Acquires Company Stock Options Worth 17,500 Shares
August 4, 2023 | benzinga.com
Chairman at Microbot Medical Acquires Company Stock Options Worth 80,000 Shares
July 11, 2023 | finance.yahoo.com
Microbot Medical Expands its Physician Support with the Addition of Leading Italian Interventional Radiologist Irene Bargellini, M.D., to its Scientific Advisory Board
June 29, 2023 | finanznachrichten.de
Microbot Medical Inc.: Microbot Medical Raises a Total of $7.6 Million in Gross Proceeds from Four Recent Registered Direct Offerings
June 29, 2023 | finance.yahoo.com
Microbot Medical Successfully Completes an Extensive Pre-Clinical Study Performed in the US
June 28, 2023 | finance.yahoo.com
Microbot Medical Raises a Total of $7.6 Million in Gross Proceeds from Four Recent Registered Direct Offerings
June 27, 2023 | finance.yahoo.com
Microbot Medical Announces $2 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
June 23, 2023 | markets.businessinsider.com
H.C. Wainwright Sticks to Its Buy Rating for Microbot Medical (MBOT)
June 22, 2023 | finance.yahoo.com
Microbot Medical Expand IP protection in Japan
June 16, 2023 | finance.yahoo.com
Microbot Medical Announces Multiple Peer Reviewed Abstracts Accepted by The Cardiovascular and Interventional Radiological Society of Europe
June 6, 2023 | msn.com
HC Wainwright & Co. Reiterates Microbot Medical (MBOT) Buy Recommendation
June 6, 2023 | finance.yahoo.com
Microbot Medical Announces Closing of $1.5 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
June 2, 2023 | finance.yahoo.com
Microbot Medical Announces $1.5 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
June 2, 2023 | finance.yahoo.com
Microbot Medical Receives a Non-Dilutive Grant from The Israel Innovation Authority Supporting the Development of the Manufacturing Process for its Endovascular Surgical Robotic System
May 31, 2023 | finance.yahoo.com
LIBERTY Robotic Surgical System Achieved Additional Milestone in its Path to First in Human and Regulatory Process
May 25, 2023 | finance.yahoo.com
Lahey Hospital & Medical Center Agrees to become One of the U.S. Sites for the LIBERTY® Robotic System’s First Human Trial
May 25, 2023 | finance.yahoo.com
Lahey Hospital & Medical Center Agrees to become One of the U.S. Sites for the LIBERTY® Robotic System’s First Human Trial
May 24, 2023 | finance.yahoo.com
Microbot Medical Announces Closing of $2.66 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules
See More Headlines
Receive MBOT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Microbot Medical and its competitors with MarketBeat's FREE daily newsletter.

MBOT Company Calendar

Last Earnings
8/14/2023
Today
9/27/2023
Next Earnings (Estimated)
11/13/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:MBOT
CUSIP
N/A
CIK
883975
Web
www.microbotmedical.com
Phone
(781) 875-3605
Fax
781-556-5347
Employees
18
Year Founded
2010

Price Target and Rating

Average Stock Price Forecast
$8.00
High Stock Price Forecast
$8.00
Low Stock Price Forecast
$8.00
Forecasted Upside/Downside
+501.5%
Consensus Rating
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

EPS (Most Recent Fiscal Year)
($1.48)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-13,170,000.00
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-171.07%
Return on Assets
-136.39%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
7.81
Quick Ratio
7.81

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.02 per share
Price / Book
0.66

Miscellaneous

Outstanding Shares
11,710,000
Free Float
10,461,000
Market Cap
$15.58 million
Optionable
Not Optionable
Beta
3.22

Social Links

Elon Musk's Next Move Cover
Elon Musk's Next Move

Wondering when you'll finally be able to invest in SpaceX, StarLink or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

  • Mr. Harel Gadot (Age 50)
    Co-Founder, Pres, CEO & Chairman
    Comp: $941.8k
  • Mr. Yoseph Bornstein (Age 64)
    Co-Founder & Independent Director
    Comp: $52.5k
  • Ms. Rachel Vaknin (Age 44)
    Chief Financial Officer
    Comp: $189.38k
  • Dr. Simon Sharon MBA (Age 62)
    MSc, CTO & GM of Microbot Israel
    Comp: $461.22k
  • Dr. Eyal Morag M.D. (Age 58)
    Chief Medical Officer & Member of Scientific Advisory Board
    Comp: $510.43k
  • Prof. Moshe Shoham D.Sc. (Age 71)
    Co-Founder, Scientific Director & Chairman of Scientific Advisory Board

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions













MBOT Stock - Frequently Asked Questions

What is Microbot Medical's stock price forecast for 2023?

0 brokerages have issued twelve-month price objectives for Microbot Medical's stock. Their MBOT share price forecasts range from $8.00 to $8.00. On average, they expect the company's share price to reach $8.00 in the next twelve months. This suggests a possible upside of 501.5% from the stock's current price.
View analysts price targets for MBOT or view top-rated stocks among Wall Street analysts.

How have MBOT shares performed in 2023?

Microbot Medical's stock was trading at $3.01 on January 1st, 2023. Since then, MBOT shares have decreased by 55.8% and is now trading at $1.3301.
View the best growth stocks for 2023 here.

When is Microbot Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, November 13th 2023.
View our MBOT earnings forecast.

How were Microbot Medical's earnings last quarter?

Microbot Medical Inc. (NASDAQ:MBOT) announced its quarterly earnings data on Monday, August, 14th. The biotechnology company reported ($0.25) EPS for the quarter, beating analysts' consensus estimates of ($0.31) by $0.06.

When did Microbot Medical's stock split?

Microbot Medical's stock reverse split before market open on Monday, May 9th 2016. The 1-12 reverse split was announced on Friday, May 6th 2016. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 6th 2016. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split.

What other stocks do shareholders of Microbot Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Microbot Medical investors own include Advanced Micro Devices (AMD), Athersys (ATHX), NVIDIA (NVDA), Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Novavax (NVAX), Pfizer (PFE), Micron Technology (MU) and Sorrento Therapeutics (SRNE).

What is Microbot Medical's stock symbol?

Microbot Medical trades on the NASDAQ under the ticker symbol "MBOT."

Who are Microbot Medical's major shareholders?

Microbot Medical's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (1.69%), Renaissance Technologies LLC (1.08%), Bank of New York Mellon Corp (0.65%), Hilltop Holdings Inc. (0.23%), Wells Fargo & Company MN (0.16%) and Cutler Group LLC CA (0.00%).
View institutional ownership trends.

How do I buy shares of Microbot Medical?

Shares of MBOT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Microbot Medical's stock price today?

One share of MBOT stock can currently be purchased for approximately $1.33.

How much money does Microbot Medical make?

Microbot Medical (NASDAQ:MBOT) has a market capitalization of $15.58 million. The biotechnology company earns $-13,170,000.00 in net income (profit) each year or ($1.48) on an earnings per share basis.

How can I contact Microbot Medical?

Microbot Medical's mailing address is 25 RECREATION PARK DRIVE UNIT 108, HINGHAM MA, 02043. The official website for the company is www.microbotmedical.com. The biotechnology company can be reached via phone at (781) 875-3605, via email at mpolyviou@evcgroup.com, or via fax at 781-556-5347.

This page (NASDAQ:MBOT) was last updated on 9/27/2023 by MarketBeat.com Staff

My Account -